Roivant Sciences Ltd. (ROIV) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Roivant Sciences Ltd., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -42.56x | 1.88x | -5.21x | -3.91x | -8.28x | 5.93x |
| P/B Ratio | 1.56x | 1.37x | 4.54x | 2.00x | 3.53x | 3.50x |
| P/S Ratio | 251.93x | 249.73x | 85.84x | 59.84x | 281.46x | 105.21x |
| Profitability | ||||||
| Gross Margin | 96.9% | 95.1% | 78.6% | 83.8% | 91.4% | 98.3% |
| Operating Margin | -3453.3% | 13746.9% | -1917.9% | -2444.8% | -4500.5% | -786.6% |
| Net Margin | -592.0% | 13294.2% | -1646.6% | -1528.9% | -3400.9% | 1773.6% |
| EBITDA Margin | -3784.8% | -2454.4% | -1922.3% | -1647.4% | -3028.3% | -817.4% |
| Liquidity | ||||||
| Current Ratio | 33.47x | 25.24x | 6.60x | 11.64x | 9.99x | 24.09x |
| Quick Ratio | 33.47x | 25.10x | 6.59x | 11.64x | 9.99x | 24.09x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.08x | 0.42x | 0.17x | 0.13x | 0.09x |
YoY = year-over-year change. Source: FMP..